What is the Projected CAGR value of the Liquid Biopsy Market?
Liquid Biopsy Market is expected to grow at a high CAGR of 15.4% during the forecasting period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Liquid Biopsy Market during 2023-2030.
Which is the fastest growing region in the Liquid Biopsy Market?
Among all regions, Asia Pacific is the fastest growing market share during the forecast period.
Who are the Key Players of Liquid Biopsy Market ?
The major global players in the market include Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Exosome Sciences Inc., Grail Inc, Guardant Health, Thermo Fisher Scientific Inc., Inivata Ltd, Illumina Inc, LungLife AI Inc, and Qiagen NV among others.